Analysed Oncotelic Therapeutics Inc (OTLC:OTCMKTS) News Sources
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution
Yahoo Finance
Oncotelic Therapeutics, Inc.: Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution
FinanzNachrichten.de
Biomednewsbreaks Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured In Networknewsaudio On Biotech M&A Trends
MENAFN
NetworkNews Audio Announces Audio Press Release (APR) Discussing Growing Investor Attention on Companies Holding Clinical-Stage Portfolios
The Manila Times
NetworkNews Audio Announces Audio Press Release (APR) Discussing Growing Investor Attention on ...
The Bakersfield Californian
What is the current price of Oncotelic Therapeutics Inc (OTLC:OTCMKTS)?
The current price of Oncotelic Therapeutics Inc (OTLC:OTCMKTS) is $0.04598.
Oncotelic Therapeutics Inc (OTLC:OTCMKTS) absolute price change since previous trading day?
The absolute price change of Oncotelic Therapeutics Inc (OTLC:OTCMKTS) since the previous trading day is $-0.00.
Oncotelic Therapeutics Inc (OTLC:OTCMKTS) percentage price change since previous trading day?
The percentage price change of Oncotelic Therapeutics Inc (OTLC:OTCMKTS) since the previous trading day is -0.04%.
What is This Week's average sentiment score for Oncotelic Therapeutics Inc (OTLC:OTCMKTS)?
This Week's average sentiment score for Oncotelic Therapeutics Inc (OTLC:OTCMKTS) is 85 out of 100.
What is This Week's average sentiment for Oncotelic Therapeutics Inc (OTLC:OTCMKTS)?
This Week's sentiment for Oncotelic Therapeutics Inc (OTLC:OTCMKTS) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.